Description
SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients, providing custom manufacturing services and a broad portfolio of APIs, intermediates, and specialty ingredients. Operating 16 manufacturing plants and 9 R&D centers across Europe, North America, and Asia, the company serves over 1,500 customers in 80+ countries with annual revenue of €1.1 billion.